{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "multicenter randomized controlled trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Patients were randomized to receive"
      },
      "Participants": {
        "score": 2,
        "evidence": "in kidney transplant recipients (KTRs)"
      },
      "Intervention": {
        "score": 2,
        "evidence": "single dose of mRNA-1273 (100 \u03bcg, n\u2005=\u200525), a double dose of mRNA-1273 (2\u2009\u00d7\u2009100 \u03bcg, n\u2005=\u200525), or a single dose of adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2.S) (n\u2005=\u200525)"
      },
      "Objective": {
        "score": 1,
        "evidence": "investigating different repeated vaccination strategies in KTR who showed poor serological responses"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "compared SARS-CoV-2-specific interleukin-21 memory T-cell and B-cell responses"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomized to receive"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "n\u2005=\u200525"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "odd ratio, 3.84 [1.89-7.78]; P <\u20050.001"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT05030974"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  },
  "model": "gpt-4o"
}